Dr. Eddrice McMullan praises Accuro for increasing first-attempt success rates and reducing needle passes and placement times, especially in patients with high BMI or scoliosis. “It’s genius,” she says, emphasizing its effectiveness when traditional methods fall short.
Recent Posts
- Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes
- RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
- Advancing Obstetric Anesthesia: Dr. Steven Garber on the Real-World Power of Accuro 3S
- Building Healthcare Equity in Modern Health Systems
- Up to 92% First-Attempt Success: How AI Quality Improvement Is Transforming Neuraxial Anesthesia